Viridian Therapeutics
VRDN
VRDN
122 hedge funds and large institutions have $1.21B invested in Viridian Therapeutics in 2022 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 52 increasing their positions, 29 reducing their positions, and 12 closing their positions.
Holders
122
Holders Change
+17
Holders Change %
+16.19%
% of All Funds
1.97%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.18%
New
30
Increased
52
Reduced
29
Closed
12
Calls
$3.47M
Puts
$3.58M
Net Calls
-$109K
Net Calls Change
-$3.08M
Top Buyers
Top Sellers
| 1 |
CC
1
Commodore Capital
New York
|
$59M |
| 2 |
2
Barclays
London,
United Kingdom
|
$2.9M |
| 3 |
BI
3
BVF Inc
San Francisco,
California
|
$36.2M |
| 4 |
GTC
4
Ghost Tree Capital
New York
|
$4.82M |
| 5 |
EP
5
Eversept Partners
New York
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
BNP Paribas Financial Markets
Paris,
France
| – | -$727K | -35,445 | Closed |
|
|
PHP
127
Parkman Healthcare Partners
Stamford,
Connecticut
| – | -$725K | -35,358 | Closed |
|
128
Walleye Trading
New York
| – | -$556K | -27,118 | Closed |
|
|
SGM
129
Seven Grand Managers
Bronxville,
New York
| – | -$513K | -25,000 | Closed |
|
|
AA
130
ALPS Advisors
Denver,
Colorado
| – | -$428K | -20,848 | Closed |
|
|
SCM
131
Soleus Capital Management
Greenwich,
Connecticut
| – | -$400K | -19,518 | Closed |
|
|
OQS
132
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
| – | -$323K | -15,764 | Closed |
|
133
Wells Fargo
San Francisco,
California
| – | -$16K | -808 | Closed |
|